Bill > SB400

This bill modifies the duties and reporting requirements of the Therapeutic Cannabis Medical Oversight Board, which appears to be a state-level board responsible for overseeing medical cannabis regulations. Specifically, the bill requires the board to conduct an annual review of medical and scientific evidence related to currently approved qualifying conditions for medical cannabis and potential additional qualifying conditions. Moreover, the board must now include citations to the medical and scientific evidence it reviews in its annual report, which is submitted to several key state entities including the senate president, house speaker, health and human services oversight committee, board of medicine, and board of nursing. The bill will take effect 60 days after its passage, and it aims to increase transparency and evidence-based decision-making in the state's medical cannabis program by mandating a systematic annual review and documentation of medical research.